Olaf Bodamer, M.D., Ph.D., FAAP, FACMG
- American Board of Medical Gen-Medical Biochemical Genetics
- Clinical Genetics(MD)-Medical Genetics
- Analysis of glucocerebrosidase activity in dry blood spots using tandem mass spectrometry.
- Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry.
- Semi-quantitative method for determination of hematocrit in dried blood spots using data collected in HPLC hemoglobin variant testing.
- The identification of novel mutations in the biotinidase gene using denaturing high pressure liquid chromatography (dHPLC).
- List of Publications
Olaf A. Bodamer, M.D., Ph.D., FACMG, FAAP, is a Professor in the Dr. John T. Macdonald Foundation Department of Human Genetics, and Director of the Division of Clinical and Translational Genetics and Clinical Vice Chair. Dr. Bodamer is board certified in Medical Genetics in Europe and in the United States. He is also board certified in Pediatrics and Biochemical Genetics in Europe. Dr. Bodamer received his medical degree with honors from Heidelberg University in Heidelberg, Germany. He also earned a doctor of medicine degree from Saarland University in Saarbrücken, Germany. Dr. Bodamer completed his genetic training at Baylor University, and is an internationally known biochemical and medical geneticist, with special interest and expertise in lysosomal storage disorders, newborn screening and genetics of prematurity.